Rituximab

Details

Files

Generic Name:

Rituximab

Project Status:

Complete

Therapeutic Area:

Granulomatosis with polyangiitis and microscopic polyangiitis

Manufacturer:

Hoffman-La Roche Ltd.

Call for patient/clinician input open:

February 24, 2012

Brand Name:

Rituxan

Project Line:

Reimbursement Review

Project Number:

SR0270-000

Call for patient/clinician input closed:

March 16, 2012

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA), remission induction (adults)

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

August 16, 2012

Last Updated : February 24, 2012